BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7854773)

  • 1. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
    Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
    Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
    Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
    Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.
    Nishida T; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
    Oncology; 1995; 52(4):340-6. PubMed ID: 7777250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis.
    Tanaka S; Haruma K; Teixeira CR; Tatsuta S; Ohtsu N; Hiraga Y; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    J Gastroenterol; 1995 Dec; 30(6):710-7. PubMed ID: 8963387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferating cell nuclear antigen and p53 protein expression in submucosal invasive colorectal carcinoma].
    Kanazawa Y; Onda M; Tanaka N; Seya T
    J Nippon Med Sch; 2000 Aug; 67(4):242-9. PubMed ID: 10938592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas.
    Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
    Cancer; 1994 Feb; 73(3):575-9. PubMed ID: 7905362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma.
    Aoki R; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
    Dis Colon Rectum; 1998 Oct; 41(10):1262-72. PubMed ID: 9788390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditions of curability after endoscopic resection for colorectal carcinoma with submucosally massive invasion.
    Tanaka S; Haruma K; Oh-E H; Nagata S; Hirota Y; Furudoi A; Amioka T; Kitadai Y; Yoshihara M; Shimamoto F
    Oncol Rep; 2000; 7(4):783-8. PubMed ID: 10854544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma.
    Tominaga K; Nakanishi Y; Nimura S; Yoshimura K; Sakai Y; Shimoda T
    Dis Colon Rectum; 2005 Jan; 48(1):92-100. PubMed ID: 15690664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
    Choi HJ; Jung IK; Kim SS; Hong SH
    Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma.
    Tateishi Y; Nakanishi Y; Taniguchi H; Shimoda T; Umemura S
    Mod Pathol; 2010 Aug; 23(8):1068-72. PubMed ID: 20473277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity.
    Nakamoto J; Torisu R; Aoki R; Kimura Y; Yasuda M; Shiota K; Yamamoto Y; Ito S
    J Med Invest; 2007 Feb; 54(1-2):99-108. PubMed ID: 17380020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of the histologic subclassification of colorectal carcinoma.
    Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 1993; 50(6):495-9. PubMed ID: 8233293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer.
    Iida A; Hirose K; Arai M; Yamaguchi A; Nakagawara G
    Oncology; 1995; 52(3):189-95. PubMed ID: 7715902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study.
    Kitajima K; Fujimori T; Fujii S; Takeda J; Ohkura Y; Kawamata H; Kumamoto T; Ishiguro S; Kato Y; Shimoda T; Iwashita A; Ajioka Y; Watanabe H; Watanabe T; Muto T; Nagasako K
    J Gastroenterol; 2004 Jun; 39(6):534-43. PubMed ID: 15235870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas.
    Taniyama K; Sasaki N; Wada S; Sasaki M; Miyoshi N; Nakai H; Kodama S; Nakatsuka H; Tahara E
    Pathol Int; 1996 Mar; 46(3):195-203. PubMed ID: 10846570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
    Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
    Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A ornithine decarboxylase activity and proliferating cell nuclear antigen in gastric cancer].
    Hoshino Y; Teranishi Y; Terashima S; Ito F; Konno A; Inoue H; Motoki R
    Nihon Geka Gakkai Zasshi; 1994 Oct; 95(10):743-52. PubMed ID: 7823896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.